Skip to main content

TCR2 Therapeutics Inc.

TCRRDelisted Jun 1, 2023
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001750019

TCR2 Therapeutics Inc. was delisted on Jun 1, 2023; its insiders filed their last Form 4 on Feb 14, 2024; 59 institutions reported holding it in 13F filings for Q1 2023, worth $31.5M in total; no superinvestor held it.

13F holders, Q4 2022

Institutional positions in TCR2 Therapeutics Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
63
−18 vs. Q3 2022
Shares held
21.2M
−3.85M (−15.4%) vs. Q3 2022
Total value
$21.2M
−$23.9M (−53.0%) vs. Q3 2022
New holders
5
15 more added
Sold out
23
23 more reduced

Compare with Q3 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TCRR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2022: 63 institutions
Q1 2021: 129 institutionsQ2 2021: 119 institutionsQ3 2021: 117 institutionsQ4 2021: 122 institutionsQ1 2022: 94 institutionsQ2 2022: 83 institutionsQ3 2022: 81 institutionsQ4 2022: 63 institutionsQ1 2023: 59 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ4 2022: $21.2M
Q1 2021: $834.8MQ2 2021: $575.3MQ3 2021: $271.1MQ4 2021: $136.0MQ1 2022: $74.8MQ2 2022: $72.2MQ3 2022: $45.1MQ4 2022: $21.2MQ1 2023: $31.5MQ2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding TCRR and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 202359$31.5M
Q4 202263$21.2M
Q3 202281$45.1M
Q2 202283$72.2M
Q1 202294$74.8M
Q4 2021122$136.0M
Q3 2021117$271.1M
Q2 2021119$575.3M
Q1 2021129$834.8M

Institutions, Q4 2022

Shares, value and share of portfolio for each institution holding TCR2 Therapeutics Inc.; share changes are against Q3 2022.

Institutions holding TCRR in Q4 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Cutler Group LP1,000$00.00%00.0%Unchanged
Royal Bank of Canada85$00.00%00.0%Unchanged
Investors Research Corp15$150.00%00.0%Unchanged
Salem Investment Counselors Inc35$350.00%00.0%Unchanged
GWM Advisors LLC47$470.00%+47New
Beaird Harris Wealth Management, LLC61$610.00%00.0%Unchanged
Federation des caisses Desjardins du Quebec500$5000.00%00.0%Unchanged
BNP Paribas Arbitrage, SA685$6840.00%+545+389.3%Added
US Bancorp700$6990.00%00.0%Unchanged
HighMark Wealth Management LLC840$8390.00%00.0%Unchanged
Advisor Group Holdings, Inc.1,350$2.00K0.00%+552+69.2%Added
Belpointe Asset Management LLC2,147$2.14K0.00%+2,147New
Lindbrook Capital, LLC3,050$3.05K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)6,937$7.00K0.00%+3,178+84.5%Added
Goldman Sachs Group Inc11,721$11.7K0.00%−28,193−70.6%Reduced
HRT Financial LP12,864$12.0K0.00%+12,864New
Independent Financial Group, LLC12,075$12.1K0.00%00.0%Unchanged
Newman Dignan & Sheerar, Inc.12,522$12.5K0.00%+1,000+8.7%Added
Bank of New York Mellon Corp12,755$12.7K0.00%00.0%Unchanged
Federated Hermes, Inc.16,711$16.7K0.00%+1,635+10.8%Added
HSBC Holdings PLC17,257$16.9K0.00%−1,544−8.2%Reduced
Virtu Financial LLC19,204$19.0K0.00%+19,204New
Commonwealth Equity Services, LLC22,473$22.0K0.00%+22,473New
Schonfeld Strategic Advisors LLC26,600$26.6K0.00%−8,800−24.9%Reduced
Wells Fargo & Company26,684$26.7K0.00%+16,471+161.3%Added
Belvedere Trading LLC31,992$32.0K0.02%+15,676+96.1%Added
X-Square Capital, LLC31,919$32.0K0.02%00.0%Unchanged
Occudo Quantitative Strategies LP32,803$32.8K0.00%00.0%Unchanged
Barclays PLC33,116$33.1K0.00%−445−1.3%Reduced
Oppenheimer & Co Inc37,950$37.9K0.00%−1,000−2.6%Reduced
Jane Street Group, LLC41,295$41.2K0.00%+25,553+162.3%Added
Ergoteles LLC45,150$45.1K0.00%−65,519−59.2%Reduced
Morgan Stanley46,395$46.3K0.00%−26,853−36.7%Reduced
Price T Rowe Associates Inc48,900$49.0K0.00%+14,700+43.0%Added
Cornercap Investment Counsel Inc68,035$68.0K0.01%00.0%Unchanged
Harbor Capital Advisors, Inc.68,230$68.1K0.07%−1,453−2.1%Reduced
Victory Capital Management Inc74,297$74.2K0.00%−9,945−11.8%Reduced
Bank of America Corp83,538$83.4K0.00%−35,129−29.6%Reduced
Northern Trust Corp86,492$86.4K0.00%−3,321−3.7%Reduced
State Street Corp109,319$109.2K0.00%00.0%Unchanged
FMR LLC113,861$113.7K0.00%+10,940+10.6%Added
Kennedy Capital Management, Inc.120,389$120.2K0.00%−190.0%Reduced
Two Sigma Investments, LP120,677$120.5K0.00%−170,891−58.6%Reduced
Millennium Management LLC140,041$140.0K0.00%−128,089−47.8%Reduced
Bridgeway Capital Management, LLC181,810$181.6K0.00%+50,000+37.9%Added
Oasis Management Co Ltd.200,000$199.8K0.04%00.0%Unchanged
Dimensional Fund Advisors LP210,118$209.0K0.00%−117,830−35.9%Reduced
Citadel Advisors LLC233,876$233.6K0.00%+41,723+21.7%Added
Two Sigma Advisers, LP249,653$249.4K0.00%−144,947−36.7%Reduced
Geode Capital Management, LLC315,377$314.0K0.00%−773−0.2%Reduced
Citigroup Inc473,484$472.9K0.00%+473,025+103,055.6%Added
JPMorgan Chase & Co524,184$524.0K0.00%−1,564−0.3%Reduced
Renaissance Technologies LLC693,286$692.0K0.00%−13,614−1.9%Reduced
Redmile Group, LLC731,379$730.5K0.03%−363,266−33.2%Reduced
Artal Group S.A.750,000$749.0K0.04%00.0%Unchanged
Baker Bros. Advisors LP753,064$752.2K0.00%00.0%Unchanged
BlackRock Inc.790,873$789.9K0.00%−234,839−22.9%Reduced
Acadian Asset Management LLC874,853$872.0K0.00%+191,739+28.1%Added
Newtyn Management, LLC1,075,000$1.07M0.22%+475,000+79.2%Added
Vanguard Group Inc1,431,346$1.43M0.00%−2,079−0.1%Reduced
Tang Capital Management LLC2,738,947$2.74M0.40%−1,002,659−26.8%Reduced
MPM Oncology Impact Management LP3,370,982$3.37M0.87%00.0%Unchanged
MPM Asset Management LLC4,050,865$4.05M1.69%00.0%Unchanged
K2 Principal Fund, L.P.0$00.00%−1,899,824−100.0%Sold out
ArrowMark Colorado Holdings LLC0$00.00%−259,672−100.0%Sold out
D. E. Shaw & Co., Inc.0$00.00%−155,495−100.0%Sold out
AlphaCentric Advisors LLC0$00.00%−151,000−100.0%Sold out
Jacobs Levy Equity Management, Inc0$00.00%−83,360−100.0%Sold out
UBS Oconnor LLC0$00.00%−54,035−100.0%Sold out
Marquette Asset Management, LLC0$00.00%−40,163−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−38,005−100.0%Sold out
First Republic Investment Management, Inc.0$00.00%−25,616−100.0%Sold out
PDT Partners, LLC0$00.00%−25,225−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−23,431−100.0%Sold out
Public Employees Retirement System of Ohio0$00.00%−18,863−100.0%Sold out
LPL Financial LLC0$00.00%−18,485−100.0%Sold out
Prelude Capital Management, LLC0$00.00%−16,715−100.0%Sold out
Connor, Clark & Lunn Investment Management Ltd.0$00.00%−14,362−100.0%Sold out
Aquatic Capital Management LLC0$00.00%−13,400−100.0%Sold out
LMR Partners LLP0$00.00%−10,880−100.0%Sold out
Guggenheim Capital LLC0$00.00%−10,622−100.0%Sold out
UBS Group AG0$00.00%−3,699−100.0%Sold out
Point72 Hong Kong Ltd0$00.00%−1,741−100.0%Sold out
China Universal Asset Management Co., Ltd.0$00.00%−361−100.0%Sold out
Daiwa Securities Group Inc.0$00.00%−131−100.0%Sold out
Wagner Wealth Management, LLC0$00.00%−275−100.0%Sold out